Funding for this research was provided by:
Cystic Fibrosis Foundation (KOPP16I0)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (1K08AI108792)
Article History
Received: 29 May 2018
Accepted: 30 October 2018
First Online: 20 November 2018
Competing Interests
: B.T.K. is a member of the US CF Advisory Board for Vertex Pharmaceuticals to provide advice on clinical trial development.